Envestnet Asset Management Inc Sarepta Therapeutics, Inc. Transaction History
Envestnet Asset Management Inc
- $302 Billion
- Q3 2024
A detailed history of Envestnet Asset Management Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 40,767 shares of SRPT stock, worth $4.94 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,767
Previous 68,679
40.64%
Holding current value
$4.94 Million
Previous $10.9 Million
53.08%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding SRPT
# of Institutions
529Shares Held
84.2MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.25 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.09 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$759 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$528 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$518 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.6B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...